Our results demonstrate that FOXD1 is highly expressed by primary tumors compared to the adjacent normal tissues and serves as a poor prognostic marker in oral cancer patients receiving irradiation therapy. The gene discussed is FOXD1; the disease is lip and oral cavity carcinoma.